Lamivudine Tablet, Film Coated
Product Images NDC 60505-3252

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 60505-3252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl150mg60s.jpg (Lbl150mg60s)

Lamivudine Tablets, USP 150 mg film-coated tablets packaging label by Apotex Corp. The label states each tablet contains 150 mg lamivudine and includes storage instructions to keep the product at 20°C to 25°C (68°F to 77°F), with permitted excursions from 15°C to 30°C (59°F to 86°F). The package contains 60 tablets with an NDC of 60505-3251-6. The label also includes the manufacturer's information and a barcode.*

FDA Label Image

Lbl300mg30s.jpg (Lbl300mg30s)

Label for Lamivudine Tablets, USP 300 mg, film-coated oral tablets. The package contains 30 tablets and is labeled for prescription use only. Manufactured by Apotex Inc., Toronto, Ontario, and distributed by Apotex Corp., Weston, Florida. The label includes storage instructions and a barcode.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure diagram of lamivudine, showing its molecular framework with nitrogen, oxygen, sulfur atoms, and functional groups as depicted in the image.*

FDA Label Image

Figure1 (Figure1)

A line graph depicting the proportions of patients with HIV-1 RNA less than 400 copies/mL over a 48-week treatment period. Two lamivudine dosage regimens are compared: 150 mg twice daily and 300 mg once daily. The x-axis represents treatment time in weeks, and the y-axis shows the proportion of patients achieving the specified viral load.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.